Creative Medical Technology Holdings, Inc.
CELZ
$2.21
-$0.07-3.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.00K | -- | -- | 3.00K | 3.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.00K | -- | -- | 3.00K | 3.00K |
| Cost of Revenue | 1.00K | -- | -- | 1.20K | 1.20K |
| Gross Profit | 2.00K | -- | -- | 1.80K | 1.80K |
| SG&A Expenses | 1.37M | 776.80K | 731.50K | 888.40K | 1.39M |
| Depreciation & Amortization | 30.90K | 31.10K | 30.70K | 30.60K | 22.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.95M | 1.27M | 1.26M | 1.66M | 1.89M |
| Operating Income | -1.95M | -1.27M | -1.26M | -1.66M | -1.89M |
| Income Before Tax | -1.89M | -1.24M | -1.23M | -1.64M | -1.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.89M | -1.24M | -1.23M | -1.64M | -1.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.89M | -1.24M | -1.23M | -1.64M | -1.85M |
| EBIT | -1.95M | -1.27M | -1.26M | -1.66M | -1.89M |
| EBITDA | -1.91M | -1.24M | -1.23M | -1.63M | -1.86M |
| EPS Basic | -0.70 | -0.48 | -0.48 | -0.83 | -1.09 |
| Normalized Basic EPS | -0.44 | -0.30 | -0.30 | -0.52 | -0.68 |
| EPS Diluted | -0.70 | -0.48 | -0.48 | -0.83 | -1.09 |
| Normalized Diluted EPS | -0.44 | -0.30 | -0.30 | -0.52 | -0.68 |
| Average Basic Shares Outstanding | 2.68M | 2.58M | 2.58M | 1.98M | 1.70M |
| Average Diluted Shares Outstanding | 2.68M | 2.58M | 2.58M | 1.98M | 1.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |